dr. oh on the development of jak inhibitors in myelofibrosis
Published 5 years ago • 231 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
1:14
dr. mesa on the emergence of jak inhibitors in myelofibrosis
-
1:14
dr. mesa on the safety profiles of jak inhibitors in myelofibrosis
-
1:30
dr. oh discusses the differences between investigational jak inhibitors and ruxolitinib in mpns
-
25:13
update on jak inhibitors for myelofibrosis: there is more than one
-
1:54
dr. mesa discusses jak inhibitors for myelofibrosis
-
0:53
investigating the place of jak inhibitors in the treatment of myelofibrosis
-
2:22
dr. mesa on the evolving role of jak2 inhibitors in myelofibrosis
-
1:34:09
jak inhibitors in myelofibrosis: expert insights on cases in personalizing therapy
-
0:58
dr. mesa on challenges with jak inhibitors in myelofibrosis
-
3:23
myelofibrosis: updates on jak inhibitors
-
1:08
dr. mesa on unanswered questions regarding jak inhibitors in myelofibrosis
-
1:01
dr. masarova on the safety of jak inhibitor/targeted therapy combos in myelofibrosis
-
2:43
dr. tefferi on the outlook for jak inhibitors in myelofibrosis
-
1:24
dr klisovic on the early use of jak inhibitors in younger patients with low-risk myelofibrosis
-
1:42
dr. mesa on jak inhibitors in the pipeline for myelofibrosis
-
1:11
dr. rossetti on the utility of jak inhibitors in mpns
-
5:11
optimal timing of jak inhibition in myelofibrosis
-
1:12
evidence supports rechallenging of jak inhibitors in myelofibrosis
-
1:46
dr. schroeder on the importance of jak inhibition in gvhd